05/01/2020

Letter and updated 'Frequently asked Questions'

Our initial request for coordinated communications to those affected by the Calea PN supply issue has been inaugurated. 

NHS England and NHS Improvement (NHSE&I) , the Medicines and Healthcare products Regulatory Agency (MHRA), the Department of Health and Social Care (DHSC), Calea and PINNT will be holding joint meetings at regular intervals.

The first meeting was held in December 2019 where a number of action points were agreed. The priority was to send a general update letter to PN patients with Calea. As the situation continues to evolve, it is important for everyone to receive the same information. The letter can be read via this link: NHS update letter

We were pleased that the updated Frequently Asked Questions (FAQ) were also sent out. The FAQs can be read via this link: Updated FAQs

To view the FAQs on the website, please use this link: https://improvement.nhs.uk/calea

Please keep the FAQs coming to us, we can will seek responses for you: please email us comms@pinnt.com